tiprankstipranks
Trending News
More News >
ADJUVANT HOLDINGS CO., LTD. (JP:4929)
:4929
Japanese Market
Advertisement

ADJUVANT HOLDINGS CO., LTD. (4929) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4929

ADJUVANT HOLDINGS CO., LTD.

(4929)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
¥816.00
▲(5.70% Upside)
The overall stock score of 62 reflects a strong financial position with minimal leverage and solid liquidity, but is tempered by concerns over declining revenue trends and inconsistent cash flow growth. The technical analysis suggests a neutral to slightly bullish outlook, while the high P/E ratio raises valuation concerns despite a reasonable dividend yield.

ADJUVANT HOLDINGS CO., LTD. (4929) vs. iShares MSCI Japan ETF (EWJ)

ADJUVANT HOLDINGS CO., LTD. Business Overview & Revenue Model

Company DescriptionAdjuvant Holdings Co.,Ltd. engages in the research, development, production, and sale of cosmetics in Japan. The company offers skin care products, including cleansing products, face washes, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeups, and body care products; hair care products comprising shampoos, treatments, scalp cleansing products, scalp lotions, and styling products; and other products. It serves hairdressing salons, barber shops, and esthetic salons. The company was formerly known as Adjuvant Cosme Japan Co.,Ltd. and changed its name to Adjuvant Holdings Co.,Ltd. in September 2021. Adjuvant Holdings Co.,Ltd. was founded in 1990 and is headquartered in Kobe, Japan.
How the Company Makes MoneyADJUVANT HOLDINGS CO., LTD. generates revenue primarily through the sale of its cosmetics and skincare products. The company employs a multi-channel sales strategy, distributing its products through direct sales, retail outlets, and online platforms. It also leverages partnerships with beauty salons and spas to expand its market reach and brand presence. The company's revenue streams are bolstered by its commitment to research and development, ensuring a steady pipeline of new and improved products that meet consumer demands for quality and effectiveness.

ADJUVANT HOLDINGS CO., LTD. Financial Statement Overview

Summary
ADJUVANT HOLDINGS CO., LTD. demonstrates a strong balance sheet with minimal leverage and a solid equity position. While profitability has improved, revenue trends are concerning, and cash flow growth has been inconsistent. The company shows potential for stability with its efficient cost management and strong liquidity, but needs to address revenue growth challenges.
Income Statement
65
Positive
The income statement shows a volatile revenue trend with a decline in recent years. The gross profit margin remains strong at approximately 64.8% for 2025, indicating efficient cost management. However, net profit margins have been inconsistent, with a significant improvement to 1% in 2025 from negative figures in prior years. EBIT and EBITDA margins have also improved, reflecting better operational efficiency, but the overall revenue decline is a concern.
Balance Sheet
75
Positive
The balance sheet is strong with a low debt-to-equity ratio of 0.007, indicating minimal leverage and financial risk. The equity ratio is high at 79%, showcasing a solid capital structure. Return on equity improved to 0.97% in 2025, recovering from negative returns in previous years. The company maintains a robust liquidity position with substantial cash reserves.
Cash Flow
70
Positive
Cash flow analysis reveals a stable operating cash flow, with a positive free cash flow in 2025. The free cash flow to net income ratio is high, suggesting efficient cash generation relative to net income. However, the free cash flow growth rate is negative compared to 2024, indicating potential challenges in sustaining cash flow growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.10B4.10B4.44B4.38B4.43B4.89B
Gross Profit2.66B2.66B2.86B2.92B2.94B3.00B
EBITDA244.00M259.63M124.00M341.54M500.79M292.22M
Net Income40.69M40.73M-99.86M403.64M393.18M142.38M
Balance Sheet
Total Assets5.29B5.29B5.28B5.55B5.66B5.10B
Cash, Cash Equivalents and Short-Term Investments2.22B2.22B2.12B1.53B1.74B1.47B
Total Debt30.51M30.51M30.82M19.18M30.08M22.96M
Total Liabilities1.11B1.11B1.06B1.06B1.34B1.00B
Stockholders Equity4.18B4.18B4.22B4.49B4.32B4.09B
Cash Flow
Free Cash Flow0.00301.91M314.89M-422.66M369.44M317.90M
Operating Cash Flow0.00307.99M377.61M-321.67M417.88M403.11M
Investing Cash Flow0.00-95.61M391.20M344.97M24.39M-235.19M
Financing Cash Flow0.00-104.55M-198.21M-256.90M-179.73M-169.56M

ADJUVANT HOLDINGS CO., LTD. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price772.00
Price Trends
50DMA
766.34
Positive
100DMA
765.15
Positive
200DMA
783.80
Negative
Market Momentum
MACD
1.72
Negative
RSI
55.02
Neutral
STOCH
64.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4929, the sentiment is Positive. The current price of 772 is above the 20-day moving average (MA) of 767.25, above the 50-day MA of 766.34, and below the 200-day MA of 783.80, indicating a neutral trend. The MACD of 1.72 indicates Negative momentum. The RSI at 55.02 is Neutral, neither overbought nor oversold. The STOCH value of 64.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4929.

ADJUVANT HOLDINGS CO., LTD. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
41.93B29.301.40%6.10%13.84%
65
Neutral
11.21B30.512.15%10.56%-52.16%
63
Neutral
6.80B10.546.46%2.22%-3.27%
62
Neutral
¥6.20B160.591.56%-9.81%
56
Neutral
6.99B14.83-20.62%
45
Neutral
5.18B20.471.65%7.21%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4929
ADJUVANT HOLDINGS CO., LTD.
771.00
-39.13
-4.83%
JP:4923
Cota Co., Ltd.
1,426.00
-199.94
-12.30%
JP:4925
HABA Laboratories, Inc.
1,799.00
-92.32
-4.88%
JP:4926
C'BON COSMETICS Co., Ltd.
1,210.00
-61.32
-4.82%
JP:4934
Premier Anti-Aging Co., Ltd.
801.00
55.00
7.37%
JP:4936
AXXZIA, Inc.
465.00
-159.25
-25.51%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 18, 2025